The value of polymixin B in endotoxaemia due to experimental obstructive jaundice and mesenteric ischaemia

Br J Surg. 1980 Aug;67(8):565-7. doi: 10.1002/bjs.1800670812.

Abstract

The role of polymixin B in endotoxaemia due to obstructive jaundice and mesenteric ischaemia has been examined. Rats made jaundiced by common bile duct ligation were challenged with intragastric endotoxin. Rats given polymixin B infusions had improved survival (11/15) compared with controls (4/14). Mesenteric ischaemia was induced in rats by clipping the mesenteric artery. Limulus assay revealed marked endotoxaemia in controls. Polymixin B infusions reduced the degree of endotoxaemia. Pre-treatment with non-absorbable intestinal antibiotics markedly reduced endotoxaemia. Polymixin B infusions gave no advantage of survival (3/10) compared with controls (2/10), but all animals pre-treated with intestinal antibiotics survived (12/12). The difference in results found between obstructive jaundice and mesenteric ischaemia may be due to different degrees of endotoxaemia. Polymixin B may have a place in the prophylaxis of endotoxaemia in clinical obstructive jaundice.

MeSH terms

  • Animals
  • Cholestasis / complications*
  • Endotoxins / blood*
  • Escherichia coli
  • Ischemia / complications*
  • Lead / pharmacology
  • Mesenteric Arteries
  • Mesenteric Vascular Occlusion / complications*
  • Polymyxin B / therapeutic use*
  • Polymyxins / therapeutic use*
  • Rats
  • Toxemia / drug therapy*
  • Toxemia / etiology

Substances

  • Endotoxins
  • Polymyxins
  • Lead
  • Polymyxin B